Home
>
Our Expertise
>
Pharma Launch Playbook
Pharma Launch Playbook
The pharmaceutical launch paradigm has evolved over the years, and with it has risen the complexity of orchestrating a successful new product launch. In an industry characterized by greater development costs, shorter patent windows, shrinking product pipelines and a growing emphasis on clinical efficacy; launching a new product requires meticulous planning at various levels.
The Best Practices, LLC pharma launch playbook serves as a comprehensive guide for launch leaders in bringing new products to market, right from the development stage to post market entry. It provides years of insights from successful launches, and highlights where exactly many of the reputed brands missed the mark - through our extensive primary benchmarking research studies and secondary research.
How We Have Helped Others with Launch Success:
Plan of Action Deployed as Others Prepare to Bring New Products to Market
- Aligning Playbook with Existing Global Templates
- Winning Cross-Functional Support and Managing Change
- Time Scope of Playbook Mapping
- Key Benchmark Dimensions of the Roadmap
- Critical Activities
- Timing, Milestones and Global-To-U.S. Handoffs
- Roles and Responsibilities
- Market Entry and Launch Investment Benchmarks
- Market Type
- FTE (Full Time Equivalents) Staffing Benchmark Levels
- Structures and Models
- HR Competencies
- Functional Scope of Roadmap
- Lessons Learned from Successful and Unsuccessful Launches
- Developing Brand Team Agility to Respond to Unexpected Changes in Market-Entry Conditions
- Market Entry Performance Metrics and Dashboards
- Covering the White Spaces for Business Development Opportunities
- Manager’s Toolkit (assemble benchmarks, timelines, milestones and key actions into a coordinated work tool)